Top Markets
Coin of the day
GenSight Biologics S.A. GenSight Biologics S.A.

GenSight Biologics S.A.

SIGHT
Classifica tra le azioni #29770
GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on... GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on identifying, advancing, and commercializing medical interventions for severe mitochondrial and neurodegenerative conditions affecting both the eyes and the central nervous system. Their therapeutic development leverages cutting-edge gene therapy platforms, specifically those involving mitochondrial targeting sequences and optogenetics. The company's leading drug candidate, LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, is currently undergoing Phase III clinical evaluation for treating Leber hereditary optic neuropathy (LHON) caused by a specific ND4 gene mutation. Another significant program, GS030, is engaged in Phase I/II clinical trials for retinitis pigmentosa and is also in the preclinical phase for dry age-related macular degeneration. Furthermore, GenSight Biologics is developing additional preclinical-stage programs aimed at various ophthalmic and neurodegenerative disorders. The company was founded in 2012 and maintains its headquarters in Paris, France.
Prezzo delle azioni
$0.1200389
Capitalizzazione di mercato
$19.57M
Variazione (1 giorno)
-3.25%
Variazione (1 anno)
-40.45%
Paese
FR
Scambia GenSight Biologics S.A. (SIGHT)

Categoria

Storico del prezzo dell'azione per GenSight Biologics S.A. (SIGHT)
Prezzo di chiusura più alto: $0.11 il 2026-08-01

Prezzo di chiusura più basso: $8.93 il 2016-07-01
Storico del prezzo dell'azione di GenSight Biologics S.A. dal 2016 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.82%
2025 -61.96%
2024 -40.41%
2023 -85.79%
2022 -40.62%
2021 -23.84%
2020 252.34%
2019 -43.91%
2018 -36.71%
2017 -20.44%
2016 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$742.10 6.97%
CH
$1.07K -5.58%
KR